# SIIT Based on UST CDST in Patients With CD

> **NCT05861167** · PHASE4 · UNKNOWN · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 140 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

- **BIOLOGICAL:** selective intensive induction therapy based on ustekinumab clinical decision-making tools

## Key facts

- **NCT ID:** NCT05861167
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2023-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05861167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05861167, "SIIT Based on UST CDST in Patients With CD". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05861167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*